J Ints Bio’s JIN-001 enhances radiation and chemotherapy to treat glioblastoma
Nov. 25, 2024
J Ints Bio Co. Ltd. has announced research findings with JIN-001, in development in collaboration with MD Anderson Cancer Center, for the treatment of brain tumors.